Introduction
Bordetella bronchiseptica (Pittman, 1984 ) is a bacterial pathogen associated with respiratory diseases in animals, particularly atrophic rhinitis in pigs (Harris & Switzer, 1968; Goodnow, 1980) . The disease state is recognised by severe changes in the nasal architecture of developing piglets, pneumonia and growth, retardation (Harris & Switzer, 1968) . We have demonstrated that protection against B. bronchiseptica-mediated atrophic rhinitis correlates with the presence of an outer-membrane protein with a molecular mass of 68 kDa as determined 1 Present address: Department of Biochemistry, Imperial College of Science, Medicine and Technology, London SW7 2AL, UK.
Abbreviations: The designations P.68/P.94, P.69/P.93, P.70/P.95 refer to the pertactin family of outer-membrane proteins expressed in B. bronchiseptica, B. pertussis and B. parapertussis respectively with molecular masses of 68, 69 and 70 kDa. The initial number (e.g. P.68) refers to the apparent molecular mass (kDa) of the processed form of the antigen that appears on the bacterial surface, while the second number (e.g. P.94) refers to the molecular mass of the unprocessed precursor as inferred from the DNA sequence.
The nucleotide sequence reported in this paper has been submitted to the EMBL Database and has been assigned the accession number X54815.
by SDS-PAGE (Novotny et al., 19853) . Antibodies to this 68 kDa protein can be detected in high titre in protected piglets, while the titre is low or absent from non-protected animals (Novotny et al., 1985 b) . Furthermore, a naturally occurring mutant of B. bronchiseptica lacking the 68 kDa protein is unable to protect piglets when used as a vaccine and is unable to induce pathological changes in infected piglets (Novotny et al., 1985b) . Administration of a vaccine consisting of a purified preparation of the 68 kDa protein to pregnant sows results in significant protection of the resulting piglets when challenged with virulent B. bronchiseptica (Kobisch & Novotny, 1990) . In addition, passively administered monoclonal antibody BB05 (Novotny et al., 1985a , specific for the 68 kDa protein) was able to prevent death from pneumonia and development of atrophic rhinitis in mice that had been aerosol-infected with a virulent strain of B. bronchiseptica.
The 68 kDa protein is a member of an immunologically cross-reactive family of Bordetella spp. outermembrane proteins that are represented in Bordetella parapertussis as a 70 kDa moiety (P.70) and in Bordetella pertussis as a 69 kDa (P.69) species. The P.69 antigen has been demonstrated to be a protective antigen against B. pertussis infections in a mouse aerosol model (Shahin et al., 1990) and in the mouse intracerebral challenge model (Novotny et al., 1985a) and is currently under evaluation as a component of future acellular vaccines against 0001-7388 O 1992 SGM whooping cough Romanos et al., 1991) . P.69 has also been shown to be an agglutinogen (Brennan et al., 1988) that can promote attachment to certain eukaryotic cells via an Arg-Gly-Asp (RGD) tripeptide sequence (Leininger et al., 199 1) . Such sequences have been characterized for a number of eukaryotic cell-cell (Ruoslahti et al., 1988) and virus-cell (Fox et al., 1989) attachment processes. Because of the cell attachment behaviour of the P.69 antigen it has been renamed pertactin, the product of the prn gene. Nothing is known about the immunological properties of the P.70 antigen from B. parapertussis, although it shares high homology with the P.69 protein (Li et al., 1991 ; Charles et al., 1989) including a putative RGD binding site.
In this paper we report the cloning and characterization of the gene encoding the 68 kDa antigen from B. bronchiseptica (P.68 pertactin) and show it to be highly homologous to its counterparts from B. pertussis and B. parapertussis. Expression of the full-length gene, capable of encoding a protein with a calculated molecular mass of 93 996 Da, in Escherichia coli results in the appearance of a 68 kDa form of the protein on the bacterial outer membrane. Native P.68 antigen can only be purified at low levels from cultures of B. bronchiseptica, but by utilizing a recombinant approach we hope to be able to produce larger samples of P.68 antigen that are completely uncontaminated by other B. bronchiseptica components. This will facilitate the understanding of both the molecular biological and immunological properties of this molecule.
Methods
Bacterial strains, plasmids and phage. B. bronchiseptica strain CN753 1 was from the Wellcome culture collection (Wellcome Biotech, UK). E. coli K 12 strains TG 1 and HB 101 were as previously described (Carter et al., 1985 ; Boyer & Roulland-Dussoix, 1969) . Cosmid pHC79 (Hohn & Collins, 1980) was from Amersham International. Plasmid pKK233-2 (Amann & Brosius, 1985) and M13mp18 and M13mp19 (YanischPerron et al., 1985) were supplied by Pharmacia. The P.69 and P.70 expression plasmids pAYLl and pBD845 have been described previously (Li et al., 1991) . Plasmid pBSSKII+ (Bluescript) was from Stratagene. E. coli strains were grown in Luria broth (LB) or LB solidified with 1.6% (w/v) agar (Miller, 1972) . B. bronchiseptica was grown in Stainer-Scholte (Stainer & Scholte, 1962) broth or medium as previously described .
DNA isolation and manipulations. B. bronchiseptica CN7531 chromosomal DNA was prepared as described previously (Hull et al., 1981) . Plasmid and bacteriophage DNA were isolated and purified by standard methods (Maniatis et al., 1982) . All DNA-modifying enzymes were from Gibco BRL.
Construction of a B. bronchiseptica genomic library. Cosmid pHC79 DNA was digested with BamHI and ligated with Sau3Adigested B. bronchiseptica DNA in the 40-50 kb size range as described previously . The gene bank was plated out and 480 randomly selected colonies transferred to microtitre plates as described previously . Colonies were transferred to Gene Screen Plus hybridization membranes (Du Pont) and hybridized with an a3*P-labelled ClaI fragment of the p m gene encoding the P.70 protein from B. parapertussis (Li et al., 1991) as described previously.
Subcloning and DNA sequencing. Recombinant phage DNA was sequenced after ligation of specific restriction endonuclease fragments of cosmid into the vectors M13mp18 and M13mp19. Sequencing was carried out using universal primer, [a3%]dATP and both gradient and wedge gels (Biggin et al., 1983; Sanger et al., 1977) . Some clones were sequenced with modified T7 DNA polymerase (Tabor & Richardson, 1987) and 7-deaza-2-dGTP (Mizusawa et al., 1986) using a kit supplied by Pharmacia. Gaps in the sequence were filled in using synthetic oligonucleotides made on a MilliGen 7500 DNA synthesizer (Millipore, UK) as specific primers (Charles et al., 1986) .
Amino acid sequencing and immunological characterization. P.68 pertactin was purified as described previously (Novotny et al., 19853) and protein sequence determined by using an Applied Biosystems 470-A gas-phase microsequencer. E. coli lysates harbouring recombinant P.68, P.69 and P.70 protein were prepared by harvesting 5 ml overnight cultures of E. coli TGl grown in L-broth harbouring either pBD881 (P.68), pAYLl (P.69) or pBD845 (P.70). Cell pellets were washed once in L-broth and 0.1 OD650 units were subjected to SDS-PAGE (Maniatis et al., 1982) . Proteins were transferred to nitrocellulose by the method of Towbin et al. (1979) . The monoclonal antibody BB05 Novotny et al., 1985a ) was used to detect P.68 protein using horse-radish-peroxidase-conjugated goat antimouse second antibody and 4-chloro-1 -naphthol as substrate (Fairweather et al., 1986) . To test for surface expression of recombinant P.68, slide agglutination assays were carried out as described previously (Li et al., 1991) .
Results

Isolation of the gene encoding the P.68 antigen
The B. bronchiseptica genomic library was screened by hybridization with a radioactively-labelled 1 08 kb ClaI fragment of thepm gene encoding the P.70 antigen from B. parapertussis (Li et al., 1991) . Of the two cosmids returning a positive signal, one, designated pBD844, was selected for further analysis. Restriction mapping and Southern blotting experiments carried out on pBD844 demonstrated that the ClaI and SalI hybridization pattern of the p m gene from B. bronchiseptica was identical to that described for both B. pertussis (Charles et al., 1989) and B. parapertussis (Li et al., 1991) . These ClaI and SalI fragments were therefore assumed to contain the entire p m gene encoding the P.68 pertactin and were cloned into Bluescript pBSSKII+ to generate pBD875 (ClaI) and pBD856 (SalI); they were also cloned into M13mp18 and M13mp19 for DNA sequencing.
Nucleotide sequence of the p m gene encoding P.68 : comparison with the equivalent genes from B. pertussis and B. parapertussis.
The DNA sequence was obtained initially from the ClaI and SalI fragments cloned into M13 and using universal 
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-- An RGD tripeptide sequence encoded by nucleotides 922-930 that occurs in the surface-exposed processed P.68 form of the protein is shown overlined. An additional RGD tripeptide motif occurs between residues 2245-2253 within the C-terminal fragment of P.94 that is clipped off during the processing of P.68. An inverted repeat followed by a run of T-residues, resembling a rho-independent transcription terminator, is shown between residues 2898-2909. 
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. antigen. this processing is likely to involve the removal of both N-terminal and C-terminal sequences . N-terminal P.68 pertactin from B. bronchiseptica 1701 protein sequencing of purified preparations of P.68 from B. bronchiseptia gave the sequence AspTrp/Gln-AsnAsn-Gln-Glnf Ser-Ile-Xaa-Lys-Ala. This sequence, despite having three regions of ambiguity, aligns with amino acid residues 35-44 in Fig. 2 and confirms that in common with the P.70 and P.69 sequences, a signal peptide is cleaved in the maturation process of P.68 pertactin. Cleavage of this signal peptide, of between 32 or 34 amino acid residues depending on which ATG initiation codon is used, occurs after the sequence AlaTyr-Ala, which is in agreement with the Ala-Xaa-Ala motif reported to be recognized by E. coli signal peptidases (Perlman & Halvorson, 1983) . Towards the C-terminus of the P.68 protein at residues 602-603 (numbering the Asp produced after signal peptide cleavage as residue 1) is a dibasic pair of amino acids, Lys-Arg, that occur in the same position, and are flanked by identical residues, as are found in the P.69 pertactin from B. pertussis. This Lys-Arg sequence in B. pertussis was originally identified as a putative cleavage site involved in the production of the mature form of the protein (Makoff et al., 1990 ). More recently, Capiau et al. (1990) have reported that purified preparations of P.69 have a C-terminal Asn residue. This Asn residue at amino acid residue position 597 is closely positioned to the Lys-Arg motif in the sequence Asn-Ala-Leu-SerLys-Arg (Fig. 29 . The precise processing events responsible for the generation of this C-terminal sequence are still unknown. A comparison of the deduced protein sequences for the P.68, P.69 and P.70 proteins (Fig. 2) demonstrates the high degree of homology between the proteins. A comparison between the P.68 and P.70 proteins shows only 17 amino acid differences, while a similar comparison between P.68 and P.69 shows 80 differences and between P.69 and P.70 there are 79 differences. The majority of amino acid differences between the three deduced protein sequences occur in the number of repeat units in the two families of repeat sequences present in all three proteins. Thus, P.68 has three copies of the GlyGly-Xaa-Xaa-Pro repeat while P.70 has four and P.69 five. Similarly, P.68 has seven Pro-Gln-Pro repeats, P.70 has nine and P.69 has five. These findings suggest that the P.68 sequence from B. bronchiseptica and the P.70 sequence from B. parapertussis are more closely related to each other than either are to the P.69 sequence from B. pertussis. The finding of close sequence homology between B. bronchiseptica and B. parapertussis is in agreement with the evolutionary trees produced by Altschul(1989) , based on a re-analysis of the sequence of the pertussis toxin operons from all three Bordetella species (Arico et al., 1987) .
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Examination of the first 140 bp of the DNA sequence in Fig. 1 shows that there are no good fits with either the consensus ribosome binding site (Shine & Dalgarno, 1975) or consensus promoter elements identified for E. coli genes (Rosenberg & Court, 1979) . In common with the genes encoding both P.68 and P.69, there is an inverted repeat after the stop codon, and then a run of Tresidues. This sequence resembles the rho-independentlike terminator that is also found at the end of the B. pertussis ptx operon (Charles et al., 1989) .
Heterologous expression of P.68 pertactin in E. coli Cosmid pBD844 harbouring the B. bronchiseptica prn gene was unable to direct the expression of P.68 pertactin in E. coli. To express the gene in E. coli, the entire structural gene was cloned into the expression plasmid pKK233-2. Fig. 3 outlines the expression strategy; an EcoRI-EcoRV fragment comprising the 5' end of P.68 prn from plasmid pBD875 was ligated into EcoRVEcoRI digested pBD856 (containing the 3' end of P.68 prn) to generate pBD876 containing the entire structural gene. Plasmid pBD876 was digested with AJ 111-Hind111 and ligated with NcoI-HindIII-digested pKK233-2. This ligation mixture was used to transform E. coli TGl and transformants expressing P.68 pertactin identified by their ability to cross-react with the mAb BB05 in protein Colonies returning a positive signal were isolated and plasmid minipreps carried out to verify that a full-length insert had been cloned. One such plasmid, pBD881, was selected for further study. Fig. 4 shows the result of a Western blot of an SDS-PAGE gel of E. coli TG1 harbouring (1) pBD845 (P.70/P.95); B. parapertussis, (2) pAYLl (P.69/.93); B. pertussis, (3) pBD881 (P.68/P.94); B. bronchiseptica and (4) pKK233-2. The arrows represent the position of bands corresponding to proteins with molecular masses of 70 kDa (B. parapertussis), 69 kDa (B. pertussis) and 68 kDa (B. bronchiseptica). For both the plasmids expressing the P.70/P.95 and P.69/P.93 proteins, larger bands corresponding to the full-length 95 kDa and 93 kDa species are present in addition to a large number of lower molecular mass bands. Surprisingly, the P.68 expression construct does not produce a detectable 94 kDa higher molecular mass band, but instead produces a pair of stronger bands at around 69 kDa and 68 kDa. The pattern of bands produced for P.69 and P.70 pertactin expression differs from that reported in our earlier work (Li et al., 1991) . This discrepancy may be due to the different growth conditions used in preparing the lysates for Western blotting. The constructs pBD881, pBD845 and pAYL1 direct the expression of P.68, P.69 and P.70, respectively, under the control of the tac promoter and IPTG induction. In preliminary experiments, the use of IPTG dot-blots. Fig. 3 . Line drawing representing the strategy used to generate the P.68 expression plasmid pBD881. Plasmids pBD875 and pBD856 contain the 5' and 3' sections of the gene encoding B. bronchisepticu pm, respectively, and were used to generate the full-length gene encoding P.94. This full-length (non-expressing) gene harboured by pBD876 was excised by digestion with AjlIII and Hind111 and ligated with NcoI-HindIII-digested pKK233-2 to generate the P.68 expressing plasmid pBD881.
to induce pertactin expression led to the accumulation of unprocessed P.94, P.93 and P.95 forms of the proteins as insoluble inclusion bodies (data not shown). In our previous work (Li et al., 1991) lysates were prepared from bacteria grown in M9 minimal medium to avoid this overexpression problem. The lysates used in this study and shown in Fig. 4 were prepared from bacteria grown in L-broth. The partial induction of the promoters under these conditions leads to the accumulation of full-length forms of P.69/93 and P.70/95 that are not processed. To test whether or not the P.68 protein was expressed on the surface of E. coli, slide agglutination assays were carried out using both monoclonal antibody BB05 and polyclonal anti-P.69 antibody (Li et al., 1991) . Agglutination occurred just as rapidly with E. coli harbouring pDB881 as with uir+ B. bronchiseptica, suggesting that the Western blot showing the expression of the pertactin family of proteins in E. coli TG1. Samples were prepared as described in Methods and reacted with the monoclonal antibody BBO5. Lanes: 1, P.70/P.95 pertactin; 2, P.69/P.93 pertactin; 3, P.68/P.94 pertactin; 4, (negative control), pKK233-2. Arrows indicate positions of protein bands corresponding to the 70 kDa, 69 kDa and 68 kDa species. There is no signal from the negative control (track 4). In lanes 1 and 2, heavy bands can be seen just below the 97 kDa molecular mass marker. These bands probably correspond to the full-length protein precursors for P.70 and P.69. By contrast, there is no apparent band for the full-length P.68 precursor. For all three proteins, lower molecular mass bands cross-reacting with BB05 monoclonal antibody indicate that the proteins are substantially degraded in E. coli.
heterologous protein is surface-located. Both the positive control strains of E. coli expressing P.69 (pAYL1) and P.70 (pBD845) on their surface were able to demonstrate agglutination (Li et al., 1991) .
Discussion
Protection against B. bronchiseptica-mediated atrophic rhinitis in animals correlates with the presence of a 68 kDa protein (Novotny et al., 1985 b) . In this paper we report the cloning, sequencing and expression of this protective antigen in E. coli. The B. bronchiseptica P.68
antigen belongs to a family of outer membrane immunologically cross-reactive proteins. In B. pertussis, a homologous protein has been characterized with a molecular mass of 69 kDa, as judged by PAGE, and has been the subject of much recent study as a potential candidate for inclusion in new generations of acellular whooping cough vaccines (Charles et al., 1989 Shahin et al., 1990 ; Novotny et al., 199 1 ; Romanos et al., 1991; Roberts et al., 1992) . So far there has been little study of the equivalent P.70 protein from B. parapertussis, although we have recently isolated and sequenced the gene encoding the protein (Li et al., 1991) . A comparison between the deduced sequences for the P.68, P.69 and P.70 pertactins reveals a high degree of homology, with the B. parapertussis and B. bronchiseptica proteins being more similar to each other than to the P.69 protein from B. pertussis. The main regions of sequence divergence between the three proteins occur in the number of repeats within the repeated regions. The region spanning the Pro-Gln-Pro family of repeats has been demonstrated to be the immunodominant part of the P.69 molecule . Differences in this region may have significance in determining the degree of immunological cross-reactivity between the different molecules, and may account for the observation that sera from piglets that cross-reacted in ELISA with preparations of P.68 failed to react with P.69 (Kobisch & Novotny, 1990 ) despite the high degree of homology between the proteins. It has been demonstrated that the P.69 protein has the ability to bind to CHO cells in culture. This binding is mediated, at least in part, by an Arg-Gly-Asp (RGD) tripeptide sequence; a mechanism that has been characterized for a variety of adhesive proteins (Ruoslahti, 1988) including B. pertussis filamentous hemagglutinin (Relman et al., 1990 ) and may suggest that P.69 has a role in bacterial adhesion. The finding of a similar RGD sequence in the P.68 pertactin also suggests that this protein may have a role in bacterial adhesion, and thus play a role in virulence. The expression of the P.68 protein on the surface of E. coli should enable us to produce recombinant protein that is uncontaminated by other B. bronchiseptica components for both immunological and cell-adhesion evaluation.
